Labshake search
Citations for Stemcell Technologies :
401 - 450 of 1145 citations for Erythromycin 90 95% Erythromycin A N N Dimethyl 13C2 ~90% 100 Ug Ml In Mtbe since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml GDNF (Stem Cell Technologies Cat # 78058), 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml BDNF (Stem Cell Technologies Cat # 78005), 20ng/ml GDNF (Stem Cell Technologies Cat # 78058) ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 100μg/mL SCF (StemCell Technologies 78062), 100μg/mL TPO (StemCell Technologies 78210.1) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ml of Collagenase IV (Stem Cell Technologies) and 25μl of 10 mg/ml DNAse I (Roche) ...
-
bioRxiv - Immunology 2021Quote: ... and 0.1 U/ml dispase (STEMCELL Technologies, #07913) in DMEM supplemented with 10% FCS ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5 mg ml-1 dispase (STEMCELL Technologies) and 1 mg ml-1 DNAse (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated with 1U/ml dispase (STEMCELL Technologies# 07923) supplemented with 0.05 mg/ml liberase (Sigma-Aldrich# 05401127001 ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Neuroscience 2022Quote: ... 5 mL N2 supplement B (StemCell Technologies, 07156)] supplemented with SB431542 (10 μM ...
-
bioRxiv - Immunology 2023Quote: ... 1 µg/ml low density lipoprotein (Stemcell Technologies), 60 µM ascorbic acid (Sigma) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant EGF (20 ng/mL, human, STEMCELL Technologies) and antibiotic antimycotic solution (100x ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL hrM-CSF (Stem Cell Technologies) and 100 nM β-Estradiol (Sigma−Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... IGF-1 (40 ng/mL; Stem Cell Technologies), cholesterol-rich lipids (40 µg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... and 20 ng/ml GM-CSF (StemCell Technologies) for 8 days at 37°C ...
-
bioRxiv - Cell Biology 2023Quote: ... 5 mL (Stem Cell Technologies cat. no. 38030)
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL ActivinA (Stem Cell Technologies, 78001), and 100 μM dbcAMP (Sigma-Aldrich ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant bFGF (20 ng/mL, human, STEMCELL Technologies), recombinant EGF (20 ng/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... on 10 µg/mL Vitronectin XF (StemCell Technologies) coated plates ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL hSCF (Stem Cell Technologies 78062), 25 ng/mL Flt3 (Stem Cell Technologies 78009 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL Flt3 (Stem Cell Technologies 78009) and 10 ng/mL TPO (STEMCELL Technologies 78210.1) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10 ng/mL TPO (STEMCELL Technologies 78210.1), 10 ng/mL EPO (STEMCELL Technologies 78007) ...
-
bioRxiv - Microbiology 2023Quote: ... using SepMate 50 ml tubes (StemCell Technologies, USA) and then directly used or frozen in fetal bovine serum (FBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Immunology 2023Quote: ... and 0.3mg/mL Collagenase IV (StemCell Technologies, #07427) for digestion at 37°C with gentle shaking ...
-
bioRxiv - Bioengineering 2023Quote: ... 1 mL gentle cell dissociation reagent (STEMCELL Technologies) was added to each well ...
-
bioRxiv - Neuroscience 2024Quote: ... and 0.02 µg/mL EGF (StemCell Technologies, #78006.1). To each well ...
-
bioRxiv - Neuroscience 2024Quote: ... rhEGF (10 ng/ml, Stem Cell Technologies #E9644), bFGF (10 ng/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... bFGF (10 ng/mL, Stem Cell Technologies #02634), N2-hormone mix (Thermo Fischer ...
-
bioRxiv - Cancer Biology 2024Quote: ... heparin (2µg/ml, Stem Cell Technologies Cat. #07980), mEGF (20ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... and heparin (10 ng/ml, Stemcell Technologies, 07980). Doubling times were computed using ...
-
bioRxiv - Cancer Biology 2024Quote: ... 100ng/mL r-Noggin (Stem Cell Technologies, 78060), 5ng/mL FGF-10 (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5ng/mL FGF-10 (Stem Cell Technologies, 78037), 37.5 ng/mL Heregulin B-1 (Peprotech ...
-
bioRxiv - Molecular Biology 2021Quote: ... the pooled samples were diluted 1:1 with PBS+2% FBS and loaded into SepMate-15™ tubes with 4.5 mL of Lymphoprep™ with a density of 1.077g/mL (StemCell Technologies). Cells were centrifuged at 1200x g for 20min at 4°C ...
-
bioRxiv - Cell Biology 2019Quote: ... insulin-like growth factor 2 (IGF2; 20 ng/ml) and fibroblast growth factor (FGF; 10 ng/ml) (BioLegend or StemCell Technologies) along with 5ug/ml polybrene (Sigma ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Bioengineering 2021Quote: ... and 25 ng/mL BMP4 with 50 ng/mL human recombinant Vascular Endothelial Growth Factor 165 (VEGF-165, STEMCELL Technologies, 78073) for 2 days ...
-
bioRxiv - Neuroscience 2021Quote: ... were isolated from E13.5 pregnant CD-1 mice and cultured on poly-D-lysine (20 μg/mL) and laminin (10 μg/mL)-coated plates in NeuroCult Basal Medium containing NeuroCult Proliferation Supplement (StemCell Technologies) and 20 ng/mL EGF ...
-
bioRxiv - Cell Biology 2021Quote: ... The resulting single cell suspension was than washed with 10 mL of cold RPMI and resuspended in 1 mL of Robosep buffer (STEMCELL technologies) prior to the negative selection of B- or T-cells ...
-
bioRxiv - Pathology 2023Quote: ... The dissociation solution was prepared by combining 30 mL of the freshly prepared stock collagenase solution with 20 mL of dispase in Hank’s balanced salt solution (Stemcell Technologies, #07913), resulting in a 60% collagenase ...
-
bioRxiv - Developmental Biology 2022Quote: ... the Matrigel was slowly diluted by removing one ml of Matrigel and adding one ml of StemFlex basal media (STEMCELL Technologies) six times to not expose coating to air ...